TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05655650 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02480504 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00703404 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00646555 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00646555 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01090674 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT01090674 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00936793 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05136040 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03878381 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00019214 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02997462 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT02001688 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04328753 — Safety Biomarker (SAF): Interleukin 1
Study NCT02919917 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04572698 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00321438 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02262338 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT03152396 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04583969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01194414 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02480062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04545034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05204758 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05204758 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02163772 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03622541 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03212599 — Predictive Biomarker (PRD): ADAM10 mRNA
Genes: ADAM10; KUZ; MADM
Study NCT01985711 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03009149 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01603979 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT01326676 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03732521 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02959853 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01126684 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01234519 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03696446 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03696446 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03696446 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00666536 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02868255 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study NCT02868255 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT02547519 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02936336 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03127553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01956994 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04827615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00390429 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01729663 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04950660 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00535444 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01952288 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01603212 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04212546 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01570062 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03914521 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00608881 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03892525 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT03892525 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00343057 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT02539719 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00412113 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00412113 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02557334 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03077243 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03077243 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03269136 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01099098 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01217879 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03590093 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT00001319 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03209011 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04717648 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02109328 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT02023918 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02023918 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01769625 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT02699125 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02376478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00044993 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04518722 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02159339 — Predictive Biomarker (PRD): GFRA1 mRNA
Genes: GFRA1; GDNFRA; RETL1; TRNR1
Study NCT01674660 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00826371 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03655301 — Predictive Biomarker (PRD): SLC47A2 mRNA
Genes: SLC47A2; MATE2
Study NCT03800498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01363336 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01363336 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02024477 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02024477 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02245464 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04572893 — Predictive Biomarker (PRD): MYH7 mRNA
Genes: MYH7; MYHCB
Study NCT04572893 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT01544478 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00000608 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02019745 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT01316809 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study NCT03891615 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02842541 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01896661 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00159380 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00477139 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02593461 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02028234 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00625014 — Safety Biomarker (SAF): DRD2
Study NCT03946852 — Predictive Biomarker (PRD): MANF mRNA
Genes: MANF; ARMET; ARP
Study NCT03946852 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT01547689 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01042054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01718613 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT03111589 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01226641 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02587858 — Predictive Biomarker (PRD): PLA2G6 mRNA
Genes: PLA2G6; PLPLA9
Study NCT01994850 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00420342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01855945 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT00253929 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT03082807 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03082807 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02945319 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT04103905 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04103905 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01520285 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02136550 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03185468 — Predictive Biomarker (PRD): UBC mRNA
Genes: UBC
Study NCT02947490 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01212679 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT03904576 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT02106104 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01695525 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02132598 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03383913 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01364857 — Predictive Biomarker (PRD): RASA1 mRNA
Genes: RASA1; GAP; RASA
Study NCT00173199 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01989572 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01346020 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT03016377 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03016377 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT00338260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01858597 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT01858597 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT01858597 — Predictive Biomarker (PRD): KLB mRNA
Genes: KLB
Study NCT02062476 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02062476 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02062476 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study NCT00405236 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT02345044 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00223912 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT00223912 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04379323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01337518 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02028676 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00185172 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00544804 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02302755 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT03456830 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT05154643 — Predictive Biomarker (PRD): Liver iron
Study NCT02608697 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT03230110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03314233 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03800264 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02423252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02423252 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02544113 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00797706 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01450969 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT02909244 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT02909244 — Predictive Biomarker (PRD): TTC7A mRNA
Genes: TTC7A; KIAA1140; TTC7
Study NCT00360750 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT02879539 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00788047 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01511575 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study NCT03341754 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03727412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03727412 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03727412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02202148 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02202148 — Safety Biomarker (SAF): BDNF
Study NCT02278133 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02278133 — Predictive Biomarker (PRD): RNF43 mRNA
Genes: RNF43
Study NCT02278133 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03343288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00789724 — Safety Biomarker (SAF): Interleukin 1
Study NCT00122941 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01105507 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT00157599 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02513524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03401476 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02446860 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00367978 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01675050 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02748525 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03628456 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03029767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02699294 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02728375 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03410108 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00006104 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03325348 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00857831 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03039088 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04261725 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04511871 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00945347 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT03278717 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04270149 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04270149 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04234204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03596099 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03155087 — Predictive Biomarker (PRD): PRKAA2 mRNA
Genes: PRKAA2; AMPK; AMPK2
Study NCT03155087 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT03517839 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01196468 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00053976 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04042051 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03673085 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03673085 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03990415 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01210248 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02482740 — Predictive Biomarker (PRD): GPER1 mRNA
Genes: GPER1; CEPR; CMKRL2; DRY12; GPER; GPR30
Study NCT01610219 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02461446 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04547335 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05659407 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT03078751 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03078751 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02745314 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02745314 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00563082 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT04963244 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT04405778 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT00043355 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01809509 — Predictive Biomarker (PRD): IL11 mRNA
Genes: IL11
Study NCT01809509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01663571 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT01663571 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03410095 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00805675 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03241940 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03241940 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02179424 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02227082 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02522585 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT02522585 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03193554 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03193554 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-210
Genes: MIR210
Study NCT02851797 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06238193 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04521686 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04521686 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT01262638 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03895580 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02753907 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT04901949 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT05934461 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00261625 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02058641 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01158716 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT02195999 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04300361 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study NCT02247011 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03363165 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03274206 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00753103 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02609841 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01137448 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03216252 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT03216252 — Safety Biomarker (SAF): Cytochrome c
Study NCT02515526 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02515526 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02515526 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02515526 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02515526 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03049306 — Surrogate Endpoint (SUR): Blood pressure